Abbott

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. 

CEO
Robert B. Ford
CEORobert B. Ford
Employees
115,000
Employees115,000
Headquarters
Abbott Park, Illinois
HeadquartersAbbott Park, Illinois
Founded
1888
Founded1888
Employees
115,000
Employees115,000

ABT Key Statistics

Market cap
176.33B
Market cap176.33B
Price-Earnings ratio
33.17
Price-Earnings ratio33.17
Dividend yield
2.42%
Dividend yield2.42%
Average volume
9.50M
Average volume9.50M
High today
$104.16
High today$104.16
Low today
$101.78
Low today$101.78
Open price
$104.06
Open price$104.06
Volume
1.17M
Volume1.17M
52 Week high
$133.34
52 Week high$133.34
52 Week low
$81.97
52 Week low$81.97

Stock Snapshot

With a market cap of 176.33B, Abbott(ABT) trades at $101.90. The stock has a price-to-earnings ratio of 33.17 and currently yields dividends of 2.42%.

On 2026-10-14, Abbott(ABT) stock moved within a range of $101.78 to $104.16. With shares now at $101.90, the stock is trading +0.1% above its intraday low and -2.2% below the session's peak.

Trading activity shows a volume of 1.17M, compared to an average daily volume of 9.5M.

Over the past 52 weeks, Abbott(ABT) stock has traded between a high of $133.34 and a low of $81.97.

Over the past 52 weeks, Abbott(ABT) stock has traded between a high of $133.34 and a low of $81.97.

ABT News

Simply Wall St 17h
SimpleScreen CRC Launch Could Be A Big Moment For Abbott Stock

Abbott Laboratories recently launched Ensure Max Protein 3-in-1 Muscle Support, gained FDA approval for expanded CardioMEMS HF System app capabilities, and bega...

SimpleScreen CRC Launch Could Be A Big Moment For Abbott Stock
The Motley Fool 21h
The Market Is Flashing Warning Signals Not Seen in Years. Here’s Why I Just Bought 3 of SCHD’s Dividend Kings.

The stock market is flashing a warning sign. The Shiller CAPE Ratio is approaching 42, its second-highest reading in 150 years (hit right before the dot-com cra...

The Market Is Flashing Warning Signals Not Seen in Years. Here’s Why I Just Bought 3 of SCHD’s Dividend Kings.
Zacks 1d
Should You Add Abbott Stock to Your Portfolio Ahead of Q3 Earnings?

Abbott Laboratories (ABT Quick QuoteABT - Free Report) is slated to report its third-quarter 2026 results on Oct. 21, before the opening bell. The Zacks...

Should You Add Abbott Stock to Your Portfolio Ahead of Q3 Earnings?

Analyst ratings

81%

of 31 ratings
Buy
80.6%
Hold
19.4%
Sell
0%

More ABT News

The Motley Fool 2d
Want Passive Income for Life? Here Are 2 Dividend Stocks to Buy and Never Sell

One type of stock will reward you no matter which direction the major indexes take, and that's the dividend stock. These companies share the wealth with investo...

Want Passive Income for Life? Here Are 2 Dividend Stocks to Buy and Never Sell
The Motley Fool 2d
Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026?

Healthcare investors often weigh established giants against high-growth specialists. Deciding between Abbott Laboratories (ABT +2.06%) and Intuitive Surgical (I...

Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026?
The Motley Fool 3d
AbbVie's Dividend Yield Is at Its Lowest Level Since 2018. Here's Why the Stock Is Still a Great Pick for Income Investors Anyway.

AbbVie (ABBV +1.49%) has been a favorite for income investors since spinning off from Abbott Labs (ABT +1.13%) in 2013. For much of the past 13 years, the big d...

AbbVie's Dividend Yield Is at Its Lowest Level Since 2018. Here's Why the Stock Is Still a Great Pick for Income Investors Anyway.
Simply Wall St 3d
What Is Abbott Laboratories Telling Investors With Its New Product Push?

Abbott Laboratories (NYSE:ABT) launched Ensure Max Protein 3-in-1 Muscle Support, combining protein, creatine, and HMB in one product. The group also brought S...

What Is Abbott Laboratories Telling Investors With Its New Product Push?
The Motley Fool 4d
History Says Abbott Stock Could More Than Double by 2036. Here’s Why I Just Added It to My Portfolio.

Abbott (ABT +1.13%) currently trades for less than $100 a share. A conservative base-case model suggests the healthcare stock could be worth around $210 per sha...

History Says Abbott Stock Could More Than Double by 2036. Here’s Why I Just Added It to My Portfolio.
Simply Wall St 4d
Abbott Laboratories, Why Is Fresh Attention Building Around It?

Abbott Laboratories (ABT) has been back in focus after rolling out three new FDA-backed products in quick succession, spanning nutrition, digital heart failure...

Abbott Laboratories, Why Is Fresh Attention Building Around It?
Simply Wall St 6d
Did Abbott Laboratories' Fall Catch You Out? What Investors Missed

If you only glanced at Abbott Laboratories’ headlines this year, the story looked constructive. Product launches, major diagnostics deals and raised guidance al...

Did Abbott Laboratories' Fall Catch You Out? What Investors Missed

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.